JP2008024630A - Water-in-oil type emulsion composition - Google Patents
Water-in-oil type emulsion composition Download PDFInfo
- Publication number
- JP2008024630A JP2008024630A JP2006197996A JP2006197996A JP2008024630A JP 2008024630 A JP2008024630 A JP 2008024630A JP 2006197996 A JP2006197996 A JP 2006197996A JP 2006197996 A JP2006197996 A JP 2006197996A JP 2008024630 A JP2008024630 A JP 2008024630A
- Authority
- JP
- Japan
- Prior art keywords
- component
- oil
- water
- emulsion composition
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 62
- 239000000839 emulsion Substances 0.000 title abstract description 25
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 claims abstract description 31
- -1 polyoxyethylene Polymers 0.000 claims abstract description 26
- 239000007787 solid Substances 0.000 claims abstract description 20
- 239000007762 w/o emulsion Substances 0.000 claims description 36
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 claims description 13
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 claims description 12
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 claims description 12
- 235000019271 petrolatum Nutrition 0.000 claims description 10
- 239000012188 paraffin wax Substances 0.000 claims description 8
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 claims description 6
- 239000004200 microcrystalline wax Substances 0.000 claims description 6
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 235000019809 paraffin wax Nutrition 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 229920001202 Inulin Polymers 0.000 claims description 3
- 239000004264 Petrolatum Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 3
- 229940029339 inulin Drugs 0.000 claims description 3
- 229940066842 petrolatum Drugs 0.000 claims description 3
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims description 2
- 229940049654 glyceryl behenate Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract description 13
- 229940074052 glyceryl isostearate Drugs 0.000 abstract description 4
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 abstract description 2
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 64
- 235000019198 oils Nutrition 0.000 description 56
- 210000003491 skin Anatomy 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 229920001296 polysiloxane Polymers 0.000 description 14
- 239000012071 phase Substances 0.000 description 13
- 239000004094 surface-active agent Substances 0.000 description 13
- 229920000642 polymer Polymers 0.000 description 12
- 239000004166 Lanolin Substances 0.000 description 11
- 235000019388 lanolin Nutrition 0.000 description 11
- 229940039717 lanolin Drugs 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 230000005068 transpiration Effects 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000004945 emulsification Methods 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 229960005150 glycerol Drugs 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000008385 outer phase Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 229960000984 tocofersolan Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 3
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229940022663 acetate Drugs 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000008384 inner phase Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- YVRMIDJPWCERHB-UHFFFAOYSA-N 6-hexan-2-yloxy-6-oxohexanoic acid Chemical compound CCCCC(C)OC(=O)CCCCC(O)=O YVRMIDJPWCERHB-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- AZLIXMDAMOHKAG-CVBJKYQLSA-N OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O AZLIXMDAMOHKAG-CVBJKYQLSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- YQNQNVDNTFHQSW-UHFFFAOYSA-N acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester Chemical compound CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C([N+]([O-])=O)S1 YQNQNVDNTFHQSW-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 229940092782 bentonite Drugs 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、みずみずしい使用感を有し、乳化安定性が良好な油中水型乳化組成物に関する。 The present invention relates to a water-in-oil emulsion composition having a fresh feeling of use and good emulsion stability.
乳化組成物は水中油型(O/W)及び油中水型(W/O)に大別されており、さらには油中水中油型(O/W/O)、水中油中水型(W/O/W)などのマルチタイプも存在する。これらは、従来、化粧品分野ではスキンケア用のクリーム、乳液、マッサージクリーム、メーク落としクリーム、ヘアケア用クリームなどに活用され、医薬品分野では経皮用クリームなどとして活用されている。 The emulsified compositions are roughly classified into an oil-in-water type (O / W) and a water-in-oil type (W / O), and further, an oil-in-water type (O / W / O), a water-in-oil-in-water type ( There are also multiple types such as (W / O / W). These are conventionally used in skin care creams, emulsions, massage creams, make-up removal creams, hair care creams and the like in the cosmetics field, and as transdermal creams in the pharmaceutical field.
このうち油相を外相、水相を内相とした油中水型(W/O)の乳化組成物は、油溶性の有効成分、例えばエモリエント油、油溶性の薬剤、紫外線吸収剤などを効率的に皮膚上に展開できることから、皮膚外用剤として適した剤型であり、この点において水中油型よりも優れている。 Among these, the water-in-oil (W / O) emulsion composition in which the oil phase is the outer phase and the water phase is the inner phase is efficient in using oil-soluble active ingredients such as emollient oil, oil-soluble drugs, and UV absorbers. Since it can be developed on the skin, it is a dosage form suitable as an external preparation for skin, and is superior to the oil-in-water type in this respect.
一般に、油中水型乳化組成物は水中油型乳化組成物に比べ安定性を確保することが難しいと考えられている(例えば非特許文献1参照)。
これは水中油型乳化組成物であれば非イオン界面活性剤として汎用されるポリオキシエチレンアルキル型界面活性剤のポリオキシエチレン鎖のエントロピー反発や、イオン性界面活性剤の静電反発を乳化物の安定化に活用できるのに対し、油中水型乳化組成物の場合は、調製に適しているとされる親油性の界面活性剤は、親水性(疎油性)が低い傾向にあり、そのため界面に吸着すべき界面活性剤が油相中に単分散溶解して消費される割合が大きくなり、効率的な油水界面の安定化が図りにくいなどの要因が関係している。そのため、油中水型乳化組成物においては、外相を構成する油をゲル化させ水滴を不動化するために高分子化合物を配合したり、界面活性剤を大量に配合することによって安定化を図ることが多く、乳化剤の量および種類、内水相比、水性成分の種類及びその量、油分の種類及びその量、他の安定剤の種類及びその量などの使用に制限があった。
In general, it is considered that it is difficult to ensure stability of a water-in-oil emulsion composition as compared with an oil-in-water emulsion composition (for example, see Non-Patent Document 1).
If this is an oil-in-water emulsified composition, the polyoxyethylene alkyl surfactant, which is widely used as a nonionic surfactant, is used to emulsify the entropy repulsion of the polyoxyethylene chain and the electrostatic repulsion of the ionic surfactant. In the case of water-in-oil emulsion compositions, lipophilic surfactants that are considered suitable for preparation tend to be less hydrophilic (oleophobic). This is related to factors such as the fact that the surfactant to be adsorbed on the interface is consumed in a monodisperse form dissolved in the oil phase, making it difficult to stabilize the oil-water interface efficiently. Therefore, in a water-in-oil emulsion composition, stabilization is achieved by blending a polymer compound or gelling a large amount of a surfactant in order to gel the oil constituting the outer phase and immobilize water droplets. In many cases, the amount and type of emulsifier, the ratio of the internal water phase, the type and amount of the aqueous component, the type and amount of oil, the type and amount of other stabilizers were limited.
また一般に、油中水型乳化組成物は水中油型乳化組成物に比べ外相が油性成分であることからみずみずしさにかけるという欠点を有する。このような欠点を解決するために一般的には内相の水性成分の割合を高める手法や、外相の油性成分中の揮発油分含有量を高める手法などがとられる。しかし、内相比を高めることは乳化安定性の悪化を招き、揮発油分含有量を高めることはスキンケア効果を有する残留油分が減少するためスキンケア効果が低下する。 In general, the water-in-oil type emulsion composition has a drawback that it is refreshed compared to the oil-in-water type emulsion composition because the outer phase is an oily component. In order to solve such drawbacks, generally, a technique for increasing the proportion of the aqueous component in the inner phase, a technique for increasing the volatile oil content in the oil component in the outer phase, and the like are taken. However, increasing the internal phase ratio causes deterioration in emulsion stability, and increasing the volatile oil content decreases the skin care effect because the residual oil content having a skin care effect decreases.
以上のことから油中水型乳化組成物を活用したスキンケアクリームにおいて、みずみずしい使用感と高いスキンケア効果を有し、且つ安定性を良好に保つことは困難であった。 From the above, in the skin care cream utilizing the water-in-oil emulsion composition, it has been difficult to maintain a good stability while having a fresh feeling of use and a high skin care effect.
このような点から、乳化剤としてポリエーテル変性シリコーンを用いることにより、安定性が高い油中水型乳化化粧料が開発されている(例えば特許文献1及び特許文献2参照)。この方法では高分子量(30000以上)のポリエーテル変性シリコーンを使用することが推奨されている。しかしながらポリエーテル変性シリコーンは通常、高分子界面活性剤としての挙動を呈し、高分子鎖の絡み合いに起因するべたついた使用感を与える。また、ポリエーテル変性シリコーンを乳化剤として用いた油中水型乳化化粧料は内相比が高くなると安定性が低下する。以上のことからポリエーテル変性シリコーンを乳化剤として用いた油中水型乳化化粧料でみずみずしい使用感を有するものを提供することは困難であった。 From such points, water-in-oil emulsified cosmetics with high stability have been developed by using polyether-modified silicone as an emulsifier (see, for example, Patent Document 1 and Patent Document 2). In this method, it is recommended to use a polyether-modified silicone having a high molecular weight (30000 or more). However, the polyether-modified silicone usually exhibits a behavior as a polymer surfactant and gives a sticky feeling of use due to entanglement of polymer chains. In addition, the stability of a water-in-oil emulsified cosmetic using polyether-modified silicone as an emulsifier decreases as the internal phase ratio increases. From the above, it has been difficult to provide a water-in-oil emulsified cosmetic using a polyether-modified silicone as an emulsifier, having a fresh feeling of use.
また、部分的に親水化されたポリシロキサン架橋体を用いて内水相比の高い油中水型乳化組成物を得て化粧品へ応用したものも知られている(例えば非特許文献2参照)。この方法で得られた油中水型乳化組成物は、高内相比によるみずみずしい使用感が特長である。しかしながら、この方法でエマルションを調製する際に、乳化組成物が環状シリコーン以外の油分、非極性油、極性油、直鎖シリコーンなどの配合により容易に不安定化するという問題があった。そのため油分の使用に制限が多く、高いスキンケア効果を得ることは困難であった。 In addition, a water-in-oil emulsion composition having a high internal water phase ratio obtained by using a partially hydrophilized crosslinked polysiloxane and applied to cosmetics is also known (see Non-Patent Document 2, for example). . The water-in-oil emulsion composition obtained by this method is characterized by a fresh feeling of use due to a high internal phase ratio. However, when preparing an emulsion by this method, there has been a problem that the emulsion composition is easily destabilized by blending oil other than cyclic silicone, nonpolar oil, polar oil, linear silicone and the like. Therefore, there are many restrictions on the use of oil, and it has been difficult to obtain a high skin care effect.
以上述べたように、従来の方法ではみずみずしい使用感と高いスキンケア効果を有しながら、安定性も良好な油中水型乳化組成物を提供することは困難であった。
本発明は前記従来技術の課題に鑑みてなされたものであり、皮膚に対するスキンケア効果の高い油中水型乳化組成物でありながら、高内水相比によるみずみずしい使用感を有し、かつ乳化安定性が良好である油中水型乳化組成物を提供することを目的とする。
As described above, it has been difficult to provide a water-in-oil emulsion composition having a good stability and good stability while having a fresh feeling of use and a high skin care effect by the conventional methods.
The present invention has been made in view of the above-mentioned problems of the prior art, and has a fresh feeling of use due to a high internal water phase ratio and an emulsion stability while being a water-in-oil emulsion composition having a high skin care effect on the skin. The object is to provide a water-in-oil emulsion composition having good properties.
本発明者らは前述の課題を解決すべく鋭意研究を行った結果、特定の成分を含む油中水型乳化組成物が、乳化安定性が良好であり、かつみずみずしい使用感を有する油中水型乳化組成物であることを見出し、発明を完成するに至った。 As a result of intensive studies to solve the above-mentioned problems, the present inventors have found that a water-in-oil emulsion composition containing a specific component has good emulsification stability and a fresh feeling of use. As a result, the present invention was completed.
本発明は、下記成分(A)(B)(C)を含み、さらに下記(i)〜(iii)の条件を満たすことを特徴とする油中水型乳化組成物である。
(A)モノオレイン酸グリセリン、モノイソステアリン酸グリセリンおよびポリオキシエチレングリセリルモノイソステアレートから選ばれる1種または2種以上
(B)水性成分
(C)固形油分を含む油性成分
条件:
(i)成分(A)の組成物全体に占める割合が0.1〜10質量%である。
(ii)成分(B)の水性成分が組成物全体に占める割合が70〜98質量%である。
(iii)成分(C)中の固形油分が成分(C)に対して3〜70質量%である。
The present invention is a water-in-oil emulsion composition comprising the following components (A), (B), and (C), and further satisfying the following conditions (i) to (iii):
(A) One or more selected from glyceryl monooleate, glyceryl monoisostearate and polyoxyethylene glyceryl monoisostearate (B) Aqueous component (C) Oil component condition including solid oil:
(I) The ratio which occupies for the whole composition of a component (A) is 0.1-10 mass%.
(Ii) The proportion of the aqueous component of component (B) in the entire composition is 70 to 98% by mass.
(Iii) The solid oil content in the component (C) is 3 to 70% by mass with respect to the component (C).
本発明にかかる油中水型乳化組成物は、乳化安定性が良好であり、かつみずみずしい使用感触を有するものである。また、皮膚に対するスキンケア効果も高いものである。 The water-in-oil emulsified composition according to the present invention has good emulsion stability and a fresh feeling to use. Moreover, the skin care effect with respect to skin is also high.
以下に、本発明の最良の実施の形態について説明する。
本発明にかかる油中水型乳化組成物は、(A)モノオレイン酸グリセリン、モノイソステアリン酸グリセリンおよびポリオキシエチレングリセリルモノイソステアレートから選ばれる1種または2種以上、(B)水性成分、(C)固形油分を含む油性成分、から構成されている。以下、各成分について詳述する。
The best mode of the present invention will be described below.
The water-in-oil emulsion composition according to the present invention comprises (A) one or more selected from glyceryl monooleate, glyceryl monoisostearate and polyoxyethylene glyceryl monoisostearate, (B) an aqueous component, (C) It is comprised from the oil-based component containing a solid oil component. Hereinafter, each component will be described in detail.
(成分(A))
本発明で用いられる(A)成分は、モノオレイン酸グリセリン、モノイソステアリン酸グリセリンおよびポリオキシエチレングリセリルモノイソステアレートから選ばれる1種または2種以上である。
このうちモノオレイン酸グリセリン(A−1)は、種々の公知の合成法により提供され得るものである。通常の合成法によれば、モノオレイン酸グリセリン、ジオレイン酸グリセリン、トリオレイン酸グリセリンの混合物として生成される。本発明にかかる油中水型乳化組成物を構成する成分(A)のモノオレイン酸グリセリンは純度が高いことが望ましく、純分90%以上であることが好ましい。モノオレイン酸グリセリンの精製法としては、通常分子蒸留法が用いられるが、これに限定されるものではない。例えば「MONOMULS90−O18(KOGNIS社製)」等として市販されており、これらを好適に用いることができる。
(Ingredient (A))
The component (A) used in the present invention is one or more selected from glyceryl monooleate, glyceryl monoisostearate and polyoxyethylene glyceryl monoisostearate.
Of these, glyceryl monooleate (A-1) can be provided by various known synthetic methods. According to the usual synthesis method, it is produced as a mixture of glyceryl monooleate, glycerin dioleate, and glyceryl trioleate. The component (A) glycerin monooleate constituting the water-in-oil emulsion composition according to the present invention preferably has a high purity, and preferably has a pure content of 90% or more. As a purification method of glyceryl monooleate, a molecular distillation method is usually used, but is not limited thereto. For example, it is marketed as “MONOMULS90-O18 (manufactured by KOGNIS)”, and these can be suitably used.
モノイソステアリン酸グリセリン(A−2)は、例えば「EMALEX GWIS−100EX(日本エマルジョン株式会社製)」、「NIKKOL MGIS(日光ケミカルズ社製)」等として市販されており、これらを好適に用いることができる。 Glycerol monoisostearate (A-2) is commercially available, for example, as “EMALEX GWIS-100EX (manufactured by Nippon Emulsion Co., Ltd.)”, “NIKKOL MGIS (manufactured by Nikko Chemicals)”, etc. it can.
ポリオキシエチレングリセリルイソステアレート(A−3)はポリオキシエチレンを分子構造中に有するグリセリルイソステアレートである。ポリオキシエチレン鎖のモル数は7未満であることが好ましく、7以上であると混合物としての成分(A)の親水性が増し、油中水型乳化組成物の調製としては不適切である。ポリオキシエチレングリセリルイソステアレートとしては、例えば「EMALEX GWIS−103EX(日本エマルジョン株式会社製)」、「EMALEX GWIS−105EX(日本エマルジョン株式会社製)」等として市販されており、これらを好適に用いることができる。 Polyoxyethylene glyceryl isostearate (A-3) is glyceryl isostearate having polyoxyethylene in the molecular structure. The number of moles of the polyoxyethylene chain is preferably less than 7, and if it is 7 or more, the hydrophilicity of the component (A) as a mixture increases, which is inappropriate for the preparation of a water-in-oil emulsion composition. Examples of polyoxyethylene glyceryl isostearate are commercially available as “EMALEX GWIS-103EX (manufactured by Nippon Emulsion Co., Ltd.)”, “EMALEX GWIS-105EX (manufactured by Nippon Emulsion Co., Ltd.)”, etc., and these are preferably used. be able to.
成分(A)としては、上記(A−1)成分から(A−3)成分の1種または2種以上を安定性を損なわない範囲で選ぶことができる。乳化安定性の観点からは(A−2)成分及び(A−3)成分は、それぞれ単独では(A−1)成分単独を用いて調製した場合ほど高い乳化安定性を有する油中水型乳化組成物は調製できない。一方で(A−1)成分単独を用いて調製した油中水型乳化組成物は低温において結晶析出の懸念がある。また、(A−2)成分及び(A−3)成分を組み合わせて用いることで、乳化安定性は向上する。
よって実際に幅広い温度で安定な油中水型乳化組成物を調製するにあたっては、(A−1)成分から(A−3)成分を2種以上併用することが好ましい。
As a component (A), 1 type, or 2 or more types of the (A-3) component from the said (A-1) component can be selected in the range which does not impair stability. From the viewpoint of emulsification stability, the (A-2) component and the (A-3) component are water-in-oil emulsification having higher emulsification stability as compared with the case where the component (A-1) is used alone. The composition cannot be prepared. On the other hand, the water-in-oil emulsion composition prepared using the component (A-1) alone has a risk of crystal precipitation at a low temperature. Moreover, emulsification stability improves by using combining (A-2) component and (A-3) component.
Therefore, in preparing a water-in-oil emulsion composition that is actually stable at a wide range of temperatures, it is preferable to use two or more components (A-1) to (A-3) in combination.
成分(A)の合計配合量は、油中水型乳化組成物中、0.1〜10質量%であることが好ましく、より好ましくは0.1〜5質量%である。 It is preferable that the total compounding quantity of a component (A) is 0.1-10 mass% in a water-in-oil emulsion composition, More preferably, it is 0.1-5 mass%.
(成分(B))
成分(B)の水性成分は水を主成分とするものである。また、皮膚に対するスキンケア効果の観点から保湿剤を配合することが好ましい。保湿剤としては、グリセリン、ジグリセリンなどのグリセロール類、1,3−ブチレングリコール、ポリエチレングリコール、プロピレングリコール、ジプロピレングリコール、ヘキシレングリコールなどの2価のグリコール類や、キシリトール、マルチトール、マルトース、ソルビトール、グルコースなどの糖類及びその誘導体等がある。
(Ingredient (B))
The aqueous component of the component (B) is mainly composed of water. Moreover, it is preferable to mix | blend a moisturizer from a viewpoint of the skin care effect with respect to skin. As the humectant, glycerols such as glycerin and diglycerin, 1,3-butylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, hexylene glycol and other divalent glycols, xylitol, maltitol, maltose, Examples include saccharides such as sorbitol and glucose, and derivatives thereof.
成分(B)の成分としてはその他に化粧品、医薬品に通常使用可能なものを、乳化物の安定性を損なわない範囲で使用することができる。
水溶性高分子としては、アラビアゴム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)、デンプン、アルゲコロイド(褐藻エキス)等の植物系高分子、デキストラン、プルラン等の微生物系高分子、コラーゲン、カゼイン、ゼラチン等の動物系高分子、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子、アルギン酸ナトリウム等のアルギン酸系高分子、カルボキシビニルポリマー(CARBOPOLなど)等のビニル系高分子、ポリオキシエチレン系高分子、ポリオキエチレンポリオキシプロピレン共重合体系高分子、ポリアクリル酸ナトリウム、ポリアクリルアミド等のアクリル系高分子、ベントナイト、ケイ酸アルミニウムマグネシウム、ラポナイト等の無機系水溶性高分子等がある。
金属イオン封鎖剤としては、エデト酸ナトリウム塩、メタリン酸ナトリウム、リン酸等がある。
酸化防止剤としては、アスコルビン酸、α-トコフェロール、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール等がある。
その他、各種の無機塩や有機塩類を配合することができる。
As the component (B), those that can be usually used for cosmetics and pharmaceuticals can be used as long as the stability of the emulsion is not impaired.
Examples of water-soluble polymers include plant polymers such as gum arabic, carrageenan, pectin, agar, quince seed (malmello), starch, and alge colloid (brown algae extract), microbial polymers such as dextran and pullulan, collagen, and casein. Animal polymers such as gelatin, starch polymers such as carboxymethyl starch and methylhydroxypropyl starch, alginic acid polymers such as sodium alginate, vinyl polymers such as carboxyvinyl polymer (such as CARBOPOL), polyoxyethylene Polymers, polyoxyethylene polyoxypropylene copolymer polymers, acrylic polymers such as sodium polyacrylate and polyacrylamide, inorganic water-soluble polymers such as bentonite, aluminum magnesium silicate, and laponite That.
Examples of the sequestering agent include sodium edetate, sodium metaphosphate, phosphoric acid and the like.
Examples of the antioxidant include ascorbic acid, α-tocopherol, dibutylhydroxytoluene, butylhydroxyanisole and the like.
In addition, various inorganic salts and organic salts can be blended.
本発明において、水性成分の配合量は、組成物全体に対して70〜98質量%であることが好ましく、より好ましくは75〜90質量%である。水性成分が70質量%未満では、塗布時のみずみずしさが失われ、98質量%を超えると、乳化安定性が低下する。 In this invention, it is preferable that the compounding quantity of an aqueous component is 70-98 mass% with respect to the whole composition, More preferably, it is 75-90 mass%. When the aqueous component is less than 70% by mass, freshness is lost only at the time of application, and when it exceeds 98% by mass, the emulsion stability is lowered.
(成分(C))
成分(C)の油性成分としては、液状油分、半固形油分、固形油分、種々の油溶性薬剤が含まれる。乳化物の安定性と皮膚に対するスキンケア効果の観点からは、成分(C)に対して3〜70質量%の固形油分を配合することが望ましい。ここで固形油分とは50℃以上の融点を有する油分と定義され、例えば下記の固形油分を用いることができる。
(Ingredient (C))
The oil component of component (C) includes liquid oil, semi-solid oil, solid oil, and various oil-soluble drugs. From the viewpoint of the stability of the emulsion and the skin care effect on the skin, it is desirable to blend a solid oil component of 3 to 70% by mass with respect to the component (C). Here, the solid oil component is defined as an oil component having a melting point of 50 ° C. or higher. For example, the following solid oil components can be used.
「固体油脂」としては、例えば、カカオ脂、ヤシ油、硬化ヤシ油、パーム油、パーム核油、モクロウ核油、硬化油、モクロウ、硬化ヒマシ油等が挙げられる。
「ロウ」としては、例えば、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ホホバロウ、硬質ラノリン、セラックロウ、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、POEコレステロールエーテル、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテル、パラフィンワックス、マイクロクリスタリンワックス等が挙げられる。
Examples of the “solid fat / oil” include cacao butter, coconut oil, hydrogenated coconut oil, palm oil, palm kernel oil, owl kernel oil, hydrogenated oil, molasses, hydrogenated castor oil, and the like.
Examples of the “wax” include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, whale wax, montan wax, nuka wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, reduced Examples include lanolin, jojoba wax, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, paraffin wax, and microcrystalline wax.
固形油分としては、肌上でのなじみやすさと高温安定性の観点から、中でも常温での硬度が低く、高い融点を有するパラフィンワックス、及びパラフィンワックスとマイクロクリスタリンワックスの混合物が好ましい。 The solid oil is preferably a paraffin wax having a low hardness at normal temperature and a high melting point, and a mixture of paraffin wax and microcrystalline wax, from the viewpoint of familiarity on the skin and high-temperature stability.
また成分(C)の油性成分としては、油性成分の硬度と融点を変化させることにより、肌上でのなじみやすさや高温での安定性を調整できる成分として、脂肪酸でエステル化したデキストリン及びイヌリン、およびベヘン酸エイコサン二酸グリセリルから選ばれる1種または2種以上(C1)を成分(C)に対して0.1〜30質量%含有することが望ましい。 In addition, as the oily component of the component (C), dextrin and inulin esterified with fatty acids as components that can adjust the suitability on the skin and the stability at high temperature by changing the hardness and melting point of the oily component, And it is desirable to contain 0.1-30 mass% with respect to a component (C) 1 type (s) or 2 or more types (C1) chosen from behenic acid eicosane diacid glyceryl.
さらに、成分(C)の油性成分として、高いスキンケア効果を有する半固形油分であるワセリンを含有することが望ましい。 Furthermore, it is desirable to contain petrolatum, which is a semi-solid oil component having a high skin care effect, as the oil component of component (C).
本発明においては、上記成分以外に下記の油分を成分(C)の油性成分として配合することができる。
「液体油脂」としては、例えば、アボガド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン等が挙げられる。
「炭化水素油」としては、例えば、流動パラフィン、オゾケライト、スクワラン、プリスタン、パラフィン、スクワレン等が挙げられる。
「エステル油」としては、例えば、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、12-ヒドロキシステアリン酸コレステリル、ジ-2-エチルヘキサン酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N-アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ-2-ヘプチルウンデカン酸グリセリン、トリ-2-エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ-2-エチルヘキサン酸ペンタエリスリトール、トリ-2-エチルヘキサン酸グリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン、トリイソステアリン酸トリメチロールプロパン、セチル2-エチルヘキサノエート、2-エチルヘキシルパルミテート、トリミリスチン酸グリセリン、トリ-2-ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オレイル、アセトグリセライド、パルミチン酸2-ヘプチルウンデシル、アジピン酸ジイソブチル、N-ラウロイル-L-グルタミン酸-2-オクチルドデシルエステル、アジピン酸ジ-2-ヘプチルウンデシル、エチルラウレート、セバシン酸ジ−2-エチルヘキシル、ミリスチン酸2-ヘキシルデシル、パルミチン酸2-ヘキシルデシル、アジピン酸2-ヘキシルデシル、セバシン酸ジイソプロピル、コハク酸2-エチルヘキシル、クエン酸トリエチル等が挙げられる。
「シリコーン油」としては、例えば、鎖状ポリシロキサン(例えば、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等);環状ポリシロキサン(例えば、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等)が挙げられる。
In the present invention, in addition to the above components, the following oil components can be blended as the oil component of component (C).
As `` liquid fats and oils '', for example, avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, Examples thereof include linseed oil, safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, cinnagiri oil, Japanese kiri oil, jojoba oil, germ oil, and triglycerin.
Examples of the “hydrocarbon oil” include liquid paraffin, ozokerite, squalane, pristane, paraffin, squalene and the like.
Examples of the “ester oil” include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyloctanoate, cetyl lactate , Myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl dicaprate Glycol, diisostearyl malate, glycerin di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexanoate, triisostearate Methylolpropane, tetra-2-ethylhexanoic acid pentaerythritol, tri-2-ethylhexanoic acid glycerin, trioctanoic acid glycerin, triisopalmitic acid glycerin, triisostearic acid trimethylolpropane, cetyl 2-ethylhexanoate, 2-ethylhexyl Palmitate, glyceryl trimyristate, tri-2-heptylundecanoic acid glyceride, castor oil fatty acid methyl ester, oleyl oleate, acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl-L-glutamic acid 2-octyldodecyl ester, di-2-heptylundecyl adipate, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyl adipate Shirudeshiru, diisopropyl sebacate, 2-ethylhexyl succinate, and triethyl citrate.
Examples of the “silicone oil” include linear polysiloxanes (eg, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.); cyclic polysiloxanes (eg, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodeca Methylcyclohexasiloxane, etc.).
成分(C)の成分としてはその他に化粧品、医薬品に通常使用可能なものを、乳化物の安定性を損なわない範囲で使用することができる。
紫外線吸収剤としては、パラアミノ安息香酸等の安息香酸系紫外線吸収剤、アントラミル酸メチル等のアントラニル酸系紫外線吸収剤、サリチル酸オクチル、サリチル酸フェニル等のサリチル酸系紫外線吸収剤、パラメトキシケイ皮酸イソプロピル、パラメトキシケイ皮酸オクチル、ジパラメトキシケイ皮酸モノ−2−エチルヘキサン酸グリセリル等のケイ皮酸系紫外線吸収剤、2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸等のベンゾフェノン系紫外線吸収剤、ウロカニン酸、2−(2’−ヒドロキシ−5’−メチルフェニル)ベンゾトリアゾール、4−tert−ブチル−4’−メトキシベンゾイルメタン等がある。
薬剤としては、ビタミンA油、レチノール、パルミチン酸レチノール、イノシット、塩酸ピリドキシン、ニコチン酸ベンジル、ニコチン酸アミド、ニコチン酸DL-α-トコフェロール、アスコルビン酸リン酸マグネシウム、アスコルビン酸2-グルコシド、ビタミンD2(エルゴカシフェロール)、dl-α-トコフェロール2-Lアスコルビン酸リン酸ジエステルカリウム塩、dl-α-トコフェロール、酢酸dl-α-トコフェロール、パントテン酸、ビオチン等のビタミン類、アラントイン、アズレン等の坑炎症剤、アルブチン等の美白剤、酸化亜鉛、タンニン酸等の収斂剤、イオウ、塩化リゾチーム、塩酸ピリドキシン、γ−オリザノール等がある。
また、上記薬剤は遊離の状態で使用されるほか、造塩可能なものは酸または塩基の塩の型で、またカルボン酸基を有するものはそのエステルの形で使用することができる。
油溶性高分子としては、トリメチルシロキシケイ酸、アルキル変性シリコーン、ポリアミド変性シリコーン等がある。
高分子粉末としてはジメチコンクロスポリマー、(ジメチコン/ビニルジメチコン)クロスポリマー、ポリメチルシルセスキオキサン等がある。
As the component (C), those that can be usually used for cosmetics and pharmaceuticals can be used as long as the stability of the emulsion is not impaired.
Examples of UV absorbers include benzoic acid UV absorbers such as paraaminobenzoic acid, anthranilic acid UV absorbers such as methyl anthramylate, salicylic acid UV absorbers such as octyl salicylate and phenyl salicylate, isopropyl paramethoxycinnamate, Cinnamic acid UV absorbers such as octyl paramethoxycinnamate and glyceryl mono-2-ethylhexanoate diparamethoxycinnamate, 2,4-dihydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy Benzophenone ultraviolet absorbers such as -4-methoxybenzophenone-5-sulfonic acid, urocanic acid, 2- (2′-hydroxy-5′-methylphenyl) benzotriazole, 4-tert-butyl-4′-methoxybenzoylmethane Etc.
Drugs include vitamin A oil, retinol, retinol palmitate, inosit, pyridoxine hydrochloride, benzyl nicotinate, nicotinamide, nicotinic acid DL-α-tocopherol, ascorbic acid magnesium phosphate, ascorbic acid 2-glucoside, vitamin D2 ( Ergocassipherol), dl-α-tocopherol 2-L ascorbic acid phosphate diester potassium salt, dl-α-tocopherol, dl-α-tocopherol acetate, pantothenic acid, biotin and other vitamins, allantoin, azulene and other anti-inflammation Agents, whitening agents such as arbutin, astringents such as zinc oxide and tannic acid, sulfur, lysozyme chloride, pyridoxine hydrochloride, γ-oryzanol and the like.
In addition to the above drugs being used in a free state, those capable of salt formation can be used in the form of an acid or base salt, and those having a carboxylic acid group can be used in the form of its ester.
Examples of the oil-soluble polymer include trimethylsiloxysilicic acid, alkyl-modified silicone, and polyamide-modified silicone.
Examples of the polymer powder include dimethicone crosspolymer, (dimethicone / vinyl dimethicone) crosspolymer, polymethylsilsesquioxane, and the like.
本発明の油中水型乳化組成物は、例えば次のような方法で調製することができる。
成分(A)および成分(C)を混合し、加熱して均一溶解する(パーツ1)。成分(B)およびその他の水溶性成分を混合、溶解する(パーツ2)。パーツ1を攪拌しながら加熱したパーツ2を徐添し、乳化物を調製する。次いで、調製した乳化物を攪拌しながら冷却する。
The water-in-oil emulsion composition of the present invention can be prepared, for example, by the following method.
Ingredient (A) and ingredient (C) are mixed and heated to dissolve uniformly (part 1). Ingredient (B) and other water-soluble ingredients are mixed and dissolved (part 2). While the part 1 is being stirred, the heated part 2 is gradually added to prepare an emulsion. The prepared emulsion is then cooled with stirring.
また、本発明の油中水型乳化組成物は、従来皮膚に適用されている化粧料、医薬品、および医薬部外品に広く応用することが可能である。例えば、美白用美容液、乳液、クリーム、パック、ファンデーション、マスカラ、メーク落とし、ヘアーリンス、皮膚科用軟膏等が挙げられる。 The water-in-oil emulsion composition of the present invention can be widely applied to cosmetics, pharmaceuticals, and quasi drugs that have been applied to the skin. For example, whitening serum, milk, cream, pack, foundation, mascara, make-up remover, hair rinse, dermatological ointment and the like.
以下、本発明を実施例によりさらに具体的に説明するが、これらの実施例により本発明の技術的範囲が限定的に解釈されるべきものではない。配合量は特記しない限り、その成分が配合される系に対する質量%で示す。 EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. However, the technical scope of the present invention should not be construed as being limited to these examples. Unless otherwise specified, the blending amount is expressed in mass% with respect to the system in which the component is blended.
実施例1〜19、比較例1〜8
下記表1〜表5に示す処方で、後記する方法で油中水型乳化組成物を調製し、後記する評価基準に基づいて、乳化安定性、使用感(みずみずしさ)、スキンケア効果、使用感(肌なじみのよさ)を評価した。
Examples 1-19, Comparative Examples 1-8
A water-in-oil emulsion composition is prepared by the method described later in the formulations shown in Tables 1 to 5 below, and based on the evaluation criteria described later, emulsion stability, feeling of use (freshness), skin care effect, feeling of use. (Skin familiarity) was evaluated.
(調製方法)
(1)成分(A)、成分(C)を混合し、約90度に加熱して均一溶解する。これをパーツ1とする。
(2)成分(B)およびその他の水溶性成分を混合、溶解する。これをパーツ2とする。
(3)パーツ1を強攪拌しながら約70度に加熱したパーツ2を徐添し、乳化物を調製する。
(4)(3)で調製した乳化物を攪拌しながら約40度まで冷却する。
(Preparation method)
(1) Component (A) and component (C) are mixed and heated to about 90 degrees to dissolve uniformly. This is part 1.
(2) The component (B) and other water-soluble components are mixed and dissolved. This is part 2.
(3) The part 2 heated to about 70 degree | times is added gradually, stirring the part 1, and an emulsion is prepared.
(4) Cool the emulsion prepared in (3) to about 40 degrees with stirring.
(油中水型乳化組成物の評価方法)
1.乳化安定性
油中水型乳化組成物を25℃と40℃で1ヶ月保存し、粘度(硬度)および外観を調製直後と比較し、安定性を次の基準で評価した。
◎:どの保存条件でも粘度(硬度)低下が10%以内であり、外観の変化が認められない。
○:どの保存条件でも外観の変化は認められないが、50℃で保存したもののみ10%以上の粘度(硬度)低下が認められる。
△:どの保存条件でも外観の変化は認められないが、10%以上の粘度(硬度)低下は認められる。
×:外観において水および/または油の分離が認められる。
(Evaluation method of water-in-oil emulsion composition)
1. Emulsification stability The water-in-oil emulsion composition was stored at 25 ° C. and 40 ° C. for 1 month, and the viscosity (hardness) and appearance were compared with those immediately after preparation, and the stability was evaluated according to the following criteria.
A: Viscosity (hardness) decrease is within 10% under any storage conditions, and no change in appearance is observed.
○: No change in appearance is observed under any storage conditions, but only a 10% or more decrease in viscosity (hardness) is observed when stored at 50 ° C.
Δ: No change in appearance is observed under any storage conditions, but a viscosity (hardness) decrease of 10% or more is observed.
X: Separation of water and / or oil is recognized in appearance.
2.使用感(みずみずしさ)
専門パネル10名が顔面に油中水型乳化組成物を塗布し、塗布時のみずみずしい使用感を次の基準で判定した。
○:パネルの9名以上がみずみずしいと回答
△:パネルの6名以上、9名未満がみずみずしいと回答
×:パネルの6名未満がみずみずしいと回答
2. Feeling of use (freshness)
Ten specialist panels applied the water-in-oil emulsion composition to the face, and the fresh feeling during use was determined according to the following criteria.
○: Nine or more panelists responded fresh △: Six or more panelists and less than nine responded fresh ×: Less than six panelists responded fresh
3.皮膚に対するスキンケア効果
パネル10名が油中水型乳化組成物の連用を上腕部にて一週間行い、連用前後で測定した角層水分蒸散量を比較し、次の基準で判定した。
◎:「連用後の角層水分蒸散量/連用前の角層水分蒸散量」の平均値が0.7未満
○:「連用後の角層水分蒸散量/連用前の角層水分蒸散量」の平均値が0.7以上、0.8未満
△:「連用後の角層水分蒸散量/連用前の角層水分蒸散量」の平均値が0.8以上、0.9未満
×:「連用後の角層水分蒸散量/連用前の角層水分蒸散量」の平均値が0.9以上
3. Skin Care Effect on Skin 10 panelists continuously used the water-in-oil emulsion composition in the upper arm for one week, and compared the stratum corneum moisture transpiration measured before and after the continuous use, and judged according to the following criteria.
◎: Average value of “stratified stratum moisture transpiration after continuous use / stratified stratum moisture transpiration before continuous use” is less than 0.7 ○: “stratified stratum moisture transpiration after continuous use / stratified stratum moisture transpiration before continuous use” Average value of 0.7 or more and less than 0.8 Δ: Average value of “amount of stratum corneum moisture transpiration after continuous use / amount of stratum corneum moisture transpiration before continuous use” is 0.8 or more and less than 0.9 ×: The average value of the stratum corneum water transpiration after continuous use / the stratum corneum water transpiration before continuous use is 0.9 or more.
4.使用感(肌なじみのよさ)
専門パネル10名が顔面に油中水型乳化組成物を塗布し、肌上でのなじみの良さを次の基準で判定した。
◎:パネルの9名以上がなじみが良いと回答
○:パネルの6名以上、9名未満がなじみが良いと回答
×:パネルの6名未満がなじみが良いと回答
4). Feeling of use (good skin familiarity)
Ten specialist panels applied the water-in-oil emulsion composition to the face, and determined the familiarity on the skin according to the following criteria.
◎: 9 or more people on the panel responded that they were familiar ○: 6 or more people on the panel and less than 9 responded that they were familiar ×: Less than 6 people on the panel responded that they were familiar
*1:ABIL EM90(Degussa社製)
*2:KSG210(信越化学工業社製)
*3:パラミックス91(日興リカ社製)
* 1: ABIL EM90 (manufactured by Degussa)
* 2: KSG210 (manufactured by Shin-Etsu Chemical Co., Ltd.)
* 3: Paramix 91 (manufactured by Nikko Rica)
前記表1に示す結果より明らかなように、界面活性剤としてモノオレイン酸グリセリン、モノイソステアリングリセリン、POE(5)グリセリルモノイソステアレートから選ばれる1種、または2種以上を用いることで安定性、使用性、スキンケア効果の高い油中水型乳化組成物を調製することができた。(実施例1〜4)。また界面活性剤として用いるモノオレイン酸グリセリンの純分が90%未満の場合(実施例5)と比較して、90%以上の場合(実施例2)はより乳化安定性の高い油中水型乳化組成物を調製することができる。
界面活性剤であるモノオレイン酸グリセリン、POE(5)グリセリルモノイソステアレートの配合量が多い場合(比較例1)や内相比が低い場合(比較例2)はみずみずしい使用感が失われる。また、比較例3に示すように油分として固形油分を用いない場合には乳化安定性、及びスキンケア効果が低くなる。
界面活性剤としてアルキル・ポリエーテル共変性シリコーンを用いた場合(比較例4、5)は使用感と乳化安定性の両立が困難であり、界面活性剤として架橋型ポリエーテル変性シリコーンを用いた場合(比較例6、7)はスキンケア効果と乳化安定性の両立が困難となる。
As is apparent from the results shown in Table 1, stability is achieved by using one or more kinds selected from glyceryl monooleate, monoisosteeric glycerin, POE (5) glyceryl monoisostearate as surfactants. In addition, a water-in-oil emulsion composition having high usability and skin care effect could be prepared. (Examples 1-4). Further, when the pure content of glyceryl monooleate used as the surfactant is less than 90% (Example 5), the case of 90% or more (Example 2) has a higher emulsification stability and the water-in-oil type. An emulsified composition can be prepared.
When the amounts of surfactant glyceryl monooleate and POE (5) glyceryl monoisostearate are large (Comparative Example 1) or when the internal phase ratio is low (Comparative Example 2), the fresh feeling of use is lost. Further, as shown in Comparative Example 3, when no solid oil is used as the oil, the emulsion stability and the skin care effect are lowered.
When alkyl / polyether co-modified silicone is used as a surfactant (Comparative Examples 4 and 5), it is difficult to achieve both feeling of use and emulsion stability, and when a cross-linked polyether-modified silicone is used as a surfactant In Comparative Examples 6 and 7, it is difficult to achieve both skin care effect and emulsion stability.
前記表2に示すように、界面活性剤として用いるポリオキシエチレングリセリルモノイソステアレートにおけるポリオキシエチレン部分の平均付加モル数が7以上の場合(実施例7)と比較して7未満の場合(実施例2,6)において、より乳化安定性の高い油中水型乳化組成物を調製することができる。 As shown in Table 2, the average number of added moles of the polyoxyethylene moiety in the polyoxyethylene glyceryl monoisostearate used as the surfactant is less than 7 compared to the case of 7 or more (Example 7) ( In Examples 2 and 6), a water-in-oil emulsion composition having higher emulsion stability can be prepared.
前記表3に示すように、界面活性剤としてモノオレイン酸グリセリン、モノイソステアリングリセリン、POE(5)グリセリルモノイソステアレートから選ばれる2種以上を用いることで(実施例2,8)、上記界面活性剤をそれぞれ単独で用いた場合(実施例9〜11)と比較して乳化安定性の高い油中水型乳化組成物を調製することができた。 As shown in Table 3, by using two or more kinds selected from glyceryl monooleate, monoisosteeric glycerin, and POE (5) glyceryl monoisostearate as surfactants (Examples 2 and 8), the above interface It was possible to prepare a water-in-oil emulsion composition having higher emulsification stability as compared with the case where each activator was used alone (Examples 9 to 11).
前記表4に示すように、油性成分としてワセリンを用いることで(実施例2)、用いない場合(実施例12)と比較してスキンケア効果の高い油中水型乳化組成物を調製することができた。 As shown in Table 4, by using petrolatum as the oil component (Example 2), it is possible to prepare a water-in-oil emulsion composition having a higher skin care effect than when not using (Example 12). did it.
*4:レオパールKL(千葉製粉社製)
*5:レオパールISK(千葉製粉社製)
*6:ノムコートHK−G(日清製油社製)
* 4: Leopard KL (Chiba Flour Mills)
* 5: Leopard ISK (Chiba Flour Mills)
* 6: NOMCOAT HK-G (Nisshin Oil Industries)
前記表5に示すように、油相成分中の固形油分として常温での硬度が高いマイクロクリスタリンワックスを用いた場合(実施例16)と比較すると、常温での硬度が低いパラフィンワックスやパラフィンワックスとマイクロクリスタリンワックスの混合物を用いた場合(実施例2、13〜15)では肌なじみが良い。
また、固形油分としてマイクロクリスタリンワックスを用いた場合においても、パルミチン酸デキストリン、ステアリン酸イヌリン、及びベヘン酸エイコサン二酸グリセリルを配合することで油相成分の硬度が低くなるため、肌なじみが良好となる(実施例17〜19)。
また、油相成分中の固形油分の量が多い場合(比較例8)には外相の硬度が高くなりすぎるため肌なじみは悪くなる。
As shown in Table 5, when compared to the case of using a microcrystalline wax having a high hardness at normal temperature as a solid oil component in the oil phase component (Example 16), paraffin wax and paraffin wax having a low hardness at normal temperature In the case of using a mixture of microcrystalline wax (Examples 2 and 13 to 15), the familiarity with the skin is good.
In addition, even when microcrystalline wax is used as the solid oil component, the blending of dextrin palmitate, inulin stearate, and glyceryl behenate eicosane diacid lowers the hardness of the oil phase component, so the skin familiarity is good. (Examples 17 to 19).
Further, when the amount of the solid oil in the oil phase component is large (Comparative Example 8), since the hardness of the outer phase becomes too high, the familiarity with the skin is deteriorated.
Claims (5)
(A)モノオレイン酸グリセリン、モノイソステアリン酸グリセリンおよびポリオキシエチレングリセリルモノイソステアレートから選ばれる1種または2種以上
(B)水性成分
(C)固形油分を含む油性成分
条件:
(i)成分(A)の組成物全体に占める割合が0.1〜10質量%である。
(ii)成分(B)の水性成分が組成物全体に占める割合が70〜98質量%である。
(iii)成分(C)中の固形油分が成分(C)に対して3〜70質量%である。 A water-in-oil emulsion composition comprising the following components (A), (B) and (C), and further satisfying the following conditions (i) to (ii):
(A) One or more selected from glyceryl monooleate, glyceryl monoisostearate and polyoxyethylene glyceryl monoisostearate (B) Aqueous component (C) Oil component condition including solid oil:
(I) The ratio which occupies for the whole composition of a component (A) is 0.1-10 mass%.
(Ii) The proportion of the aqueous component of component (B) in the entire composition is 70 to 98% by mass.
(Iii) The solid oil content in the component (C) is 3 to 70% by mass with respect to the component (C).
A component (C) contains petrolatum, The water-in-oil emulsion composition of Claim 1 characterized by the above-mentioned.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006197996A JP2008024630A (en) | 2006-07-20 | 2006-07-20 | Water-in-oil type emulsion composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006197996A JP2008024630A (en) | 2006-07-20 | 2006-07-20 | Water-in-oil type emulsion composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2008024630A true JP2008024630A (en) | 2008-02-07 |
Family
ID=39115639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006197996A Pending JP2008024630A (en) | 2006-07-20 | 2006-07-20 | Water-in-oil type emulsion composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008024630A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009024293A3 (en) * | 2007-08-17 | 2009-04-09 | Schwan Stabilo Cosmetics Gmbh | Structured cosmetic preparation having skin-moisturising properties |
| JP2010105952A (en) * | 2008-10-30 | 2010-05-13 | Shiseido Co Ltd | Oily solid cosmetic |
| JP2010132621A (en) * | 2008-12-05 | 2010-06-17 | Shiseido Co Ltd | Water-in-oil type emulsified cosmetic |
| WO2010110167A1 (en) | 2009-03-27 | 2010-09-30 | 株式会社 資生堂 | Water-in-oil emulsion composition |
| WO2010113930A1 (en) * | 2009-03-31 | 2010-10-07 | 株式会社資生堂 | External preparation for skin |
| JP2010229103A (en) * | 2009-03-27 | 2010-10-14 | Shiseido Co Ltd | Water-in-oil emulsion composition |
| RU2577305C2 (en) * | 2011-03-30 | 2016-03-10 | Шисейдо Компани, Лтд. | Cosmetic composition of water-in-oil type emulsion |
| JP2020164439A (en) * | 2019-03-28 | 2020-10-08 | 株式会社ヤクルト本社 | Stabilized high internal phase W / O type emulsified composition and cosmetics using it |
| EP3644939A4 (en) * | 2017-06-29 | 2021-03-17 | Shiseido Company, Ltd. | Makeup cosmetic |
| JP2021070644A (en) * | 2019-10-30 | 2021-05-06 | ロレアル | High internal aqueous phase emulsion |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS583631A (en) * | 1981-06-29 | 1983-01-10 | Kawaken Fine Chem Co Ltd | Water-in-oil type emulsion |
| JPS5987035A (en) * | 1982-11-06 | 1984-05-19 | Kawaken Fine Chem Co Ltd | W/o type emulsion composition stably containing urea |
| JPS63275518A (en) * | 1987-05-08 | 1988-11-14 | Terumo Corp | Semisolid composition |
| JPH01238513A (en) * | 1988-03-18 | 1989-09-22 | Shiseido Co Ltd | Water-in-oil type emulsified drug for external use |
| JPH03161417A (en) * | 1989-11-20 | 1991-07-11 | Kanebo Ltd | Creamy or emulsionlike water-on-oil type emulsified cosmetic |
| JPH10273433A (en) * | 1997-03-28 | 1998-10-13 | Shiseido Co Ltd | Sun-screening cosmetic |
| JP2001097818A (en) * | 1999-07-27 | 2001-04-10 | Shiseido Co Ltd | Microcapsule and its production |
| JP2002275021A (en) * | 2001-03-15 | 2002-09-25 | Kose Corp | Cosmetic |
-
2006
- 2006-07-20 JP JP2006197996A patent/JP2008024630A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS583631A (en) * | 1981-06-29 | 1983-01-10 | Kawaken Fine Chem Co Ltd | Water-in-oil type emulsion |
| JPS5987035A (en) * | 1982-11-06 | 1984-05-19 | Kawaken Fine Chem Co Ltd | W/o type emulsion composition stably containing urea |
| JPS63275518A (en) * | 1987-05-08 | 1988-11-14 | Terumo Corp | Semisolid composition |
| JPH01238513A (en) * | 1988-03-18 | 1989-09-22 | Shiseido Co Ltd | Water-in-oil type emulsified drug for external use |
| JPH03161417A (en) * | 1989-11-20 | 1991-07-11 | Kanebo Ltd | Creamy or emulsionlike water-on-oil type emulsified cosmetic |
| JPH10273433A (en) * | 1997-03-28 | 1998-10-13 | Shiseido Co Ltd | Sun-screening cosmetic |
| JP2001097818A (en) * | 1999-07-27 | 2001-04-10 | Shiseido Co Ltd | Microcapsule and its production |
| JP2002275021A (en) * | 2001-03-15 | 2002-09-25 | Kose Corp | Cosmetic |
Non-Patent Citations (1)
| Title |
|---|
| JPN6012010121; 新化粧品ハンドブック , 20061030, 第26頁,第27頁 * |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009024293A3 (en) * | 2007-08-17 | 2009-04-09 | Schwan Stabilo Cosmetics Gmbh | Structured cosmetic preparation having skin-moisturising properties |
| JP2010105952A (en) * | 2008-10-30 | 2010-05-13 | Shiseido Co Ltd | Oily solid cosmetic |
| JP2010132621A (en) * | 2008-12-05 | 2010-06-17 | Shiseido Co Ltd | Water-in-oil type emulsified cosmetic |
| CN102361626A (en) * | 2009-03-27 | 2012-02-22 | 株式会社资生堂 | Water-in-oil emulsified composition |
| WO2010110167A1 (en) | 2009-03-27 | 2010-09-30 | 株式会社 資生堂 | Water-in-oil emulsion composition |
| JP2010229103A (en) * | 2009-03-27 | 2010-10-14 | Shiseido Co Ltd | Water-in-oil emulsion composition |
| JP2010248173A (en) * | 2009-03-27 | 2010-11-04 | Shiseido Co Ltd | Water-in-oil emulsion composition |
| KR101155210B1 (en) * | 2009-03-27 | 2012-06-13 | 가부시키가이샤 시세이도 | Water in oil emulsion composition |
| WO2010113930A1 (en) * | 2009-03-31 | 2010-10-07 | 株式会社資生堂 | External preparation for skin |
| JP2010254677A (en) * | 2009-03-31 | 2010-11-11 | Shiseido Co Ltd | External preparation for skin |
| US9839588B2 (en) | 2009-03-31 | 2017-12-12 | Shiseido Company, Ltd. | Skin external preparation comprising an aqueous dispersion of finely dispersed wax, nonionic surfactant, and ionic water-soluble thickener |
| RU2577305C2 (en) * | 2011-03-30 | 2016-03-10 | Шисейдо Компани, Лтд. | Cosmetic composition of water-in-oil type emulsion |
| EP3644939A4 (en) * | 2017-06-29 | 2021-03-17 | Shiseido Company, Ltd. | Makeup cosmetic |
| JP2020164439A (en) * | 2019-03-28 | 2020-10-08 | 株式会社ヤクルト本社 | Stabilized high internal phase W / O type emulsified composition and cosmetics using it |
| JP7165090B2 (en) | 2019-03-28 | 2022-11-02 | 株式会社ヤクルト本社 | Stabilized high internal phase W/O type emulsion composition and cosmetics using the same |
| JP2021070644A (en) * | 2019-10-30 | 2021-05-06 | ロレアル | High internal aqueous phase emulsion |
| JP7508213B2 (en) | 2019-10-30 | 2024-07-01 | ロレアル | High internal aqueous phase emulsion |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4629799B2 (en) | Water-in-oil emulsion composition | |
| JP5508682B2 (en) | Oil-in-water emulsion composition and method for producing the same | |
| JP5972271B2 (en) | Oil-in-water emulsified cosmetic | |
| JP5117591B2 (en) | Water-in-oil emulsified cosmetic | |
| WO2014010622A1 (en) | Water-in-oil emulsion cosmetic | |
| KR20010006167A (en) | Oil-in-water type emulsified compositions | |
| JP2010173999A (en) | Liquid cosmetic | |
| JP2008290946A (en) | Water-in-oil type emulsion composition | |
| JP2012067049A (en) | Water-in-oil type emulsion composition | |
| JP2008024630A (en) | Water-in-oil type emulsion composition | |
| JP2005139094A (en) | Oil-in-water type skin external preparation composition | |
| JP3829048B2 (en) | Oil-in-water emulsion composition | |
| JP2004161733A (en) | O/w/o type emulsion cosmetic | |
| JP5547123B2 (en) | Water-in-oil emulsified cosmetic | |
| JP2005255667A (en) | Liquid cosmetic | |
| JP2011148750A (en) | Water in oil type emulsified skin cosmetic | |
| JP5552248B2 (en) | Water-in-oil emulsion composition | |
| JP2006273747A (en) | O/w/o type emulsion cosmetic | |
| JP3829049B2 (en) | Oil-in-water emulsion composition | |
| JP2006256971A (en) | Oil fine dispersion composition | |
| JP2008303164A (en) | Water-in-oil type solid makeup cosmetic | |
| JP2021070686A (en) | Emulsion cosmetic | |
| JP3634139B2 (en) | Oil-in-water emulsion composition | |
| JP4017254B2 (en) | Method for producing emulsified composition | |
| JP2010132620A (en) | Water-in-oil type emulsified cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Effective date: 20090601 Free format text: JAPANESE INTERMEDIATE CODE: A621 |
|
| A977 | Report on retrieval |
Effective date: 20110419 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20110531 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A521 | Written amendment |
Effective date: 20110704 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20120228 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A521 | Written amendment |
Effective date: 20120403 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120814 |
|
| A02 | Decision of refusal |
Effective date: 20121211 Free format text: JAPANESE INTERMEDIATE CODE: A02 |